Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

Androgen receptor (AR) is a validated drug target for prostate cancer based on its role in proliferation, survival, and metastases of prostate cancer cells. Unfortunately, despite recent improvements to androgen deprivation therapy and the advent of better antiandrogens with a superior affinity for...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Jacky K., Sadar, Marianne D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239799/
https://www.ncbi.nlm.nih.gov/pubmed/28144231
http://dx.doi.org/10.3389/fendo.2017.00002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239799/
https://www.ncbi.nlm.nih.gov/pubmed/28144231
http://dx.doi.org/10.3389/fendo.2017.00002

Ejemplares similares